Laura Hamill Insider Trading
Get free email notifications about insider trading for Laura Hamill.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Laura Hamill. Laura Hamill is a EVP, Worldwide Commercial Ops in GILEAD SCIENCES INC ($GILD) and a Director in ACCELERON PHARMA INC ($XLRN) and a Director in ANAPTYSBIO, INC ($ANAB) and a Director in Y-mAbs Therapeutics, Inc. ($YMAB).
Address: 333 LAKESIDE DRIVE FOSTER CITY 94404 CA
Companies in which Laura Hamill is an Insider
ACCELERON PHARMA INC
Trading Symbol: XLRNIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Laura Hamill: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Sep 17 2020
$XLRN Market Capitalization: $879.48M
$XLRN Previous Close: $23.74
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
ANAPTYSBIO, INC
Trading Symbol: ANABIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Laura Hamill: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Feb 12 2021
$ANAB Market Capitalization: $365.89M
$ANAB Previous Close: $18.54
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
GILEAD SCIENCES INC
Trading Symbol: GILDIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Laura Hamill: EVP, Worldwide Commercial Ops
Holdings: 9,840 shares
Current Value: $719,599
Latest Transaction: May 10 2019
$GILD Market Capitalization: $88.05B
$GILD Previous Close: $73.13
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Y-mAbs Therapeutics, Inc.
Trading Symbol: YMABIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Laura Hamill: Director
Holdings: 0 shares
Latest Transaction: Jun 14 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Laura Hamill
Sentiment: All, XLRN, ANAB, GILD, YMAB
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 14 2021 | YMAB | Y-mAbs Therapeutic ... | Hamill Laura | Director | Option Exercise | A | 37.53 | 16,000 | 600,480 | 16,000 | |
Feb 12 2021 | ANAB | ANAPTYSBIO, INC | Hamill Laura | Director | Option Exercise | A | 29.70 | 11,000 | 326,700 | 11,000 | |
Feb 12 2021 | ANAB | ANAPTYSBIO, INC | Hamill Laura | Director | Option Exercise | A | 29.70 | 11,000 | 326,700 | 11,000 | |
Sep 17 2020 | XLRN | ACCELERON PHARMA I ... | Hamill Laura | Director | Option Exercise | A | 101.88 | 9,339 | 951,457 | 9,339 | |
Jun 24 2020 | YMAB | Y-mAbs Therapeutic ... | Hamill Laura | Director | Option Exercise | A | 48.67 | 32,000 | 1,557,440 | 32,000 | |
Feb 13 2020 | ANAB | ANAPTYSBIO, INC | Hamill Laura | Director | Option Exercise | A | 16.56 | 11,000 | 182,160 | 11,000 | |
Sep 26 2019 | ANAB | ANAPTYSBIO, INC | Hamill Laura | Director | Option Exercise | A | 38.47 | 2,268 | 87,250 | 2,268 |